Common MS Drugs Taken Together Do Not Reduce Relapse Risk

A recent clinical trial found that interferonÎ²-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings published today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume...

http://feedproxy.google.com/~r/mnt/healthnews/~3/-gyNGU-i7Bw/257554.php

Source: Health News from Medical News Today - March 13, 2013 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news